MRK Stock Outlook 2026: Merck's Keytruda Clock Is Ticking—Here's What Comes Next
Merck (MRK) 2026 stock analysis: Keytruda's 2028 patent cliff, Winrevair growth, $112.30 price, 3% dividend, analyst targets, and US investor tax strategy.
MRK Merck Keytruda
